HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 541-552 of 4,505
Drug study icon
CompletedNCT04567524

A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules

Official study title

A Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Risperidone Extended Release Capsules in Subjects With Schizophrenia, Schizoaffective Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Long Beach
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
Lyndra Inc.
Drug study icon
CompletedNCT06627413

Safety study of Lumateperone Long-Acting Injectable Formulations in schizophrenia

Official study title

A Phase 1b, Open-label Study to Determine the Pharmacokinetics, Safety, and Tolerability of Single, Ascending Doses of Lumateperone Long-acting Injectable Formulations Administered Intramuscularly to Patients With Schizophrenia or Schizoaffective Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Los Alamitos
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Drug study icon
CompletedNCT05321602

PK Profiles of LY03010 in people with Schizophrenia or Schizoaffective Disorder

Official study title

A Randomized, Single-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Schizophrenia, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Device study icon
RecruitingNCT03217110

Cerebellar Stimulation and Cognitive Control

Official study title

Cerebellar Transcranial Magnetic Stimulation and Cognitive Control

In Iowa City
Schizophrenia, Bipolarity, ...Device studyAges 18–90
Countries
United States
Sponsor
Krystal Parker, PhD
Other study type icon
RecruitingNCT04946916

Blood markers to distinguish cognitive problems in psychiatric and brain diseases

About this title

Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease

Read the official source — NCT04946916
Official study title

Validation of Serum Neurofilament Light Chain as a Biomarker to Differentiate Cognitive Impairment From Neurodegenerative or Psychiatric Diseases

In Bron
Schizophrenia, BipolarityStudy assessmentsAges 45–80
Countries
France
Sponsor
Hôpital le Vinatier
Other study type icon
RecruitingACTRN12612000291886

Physical activity for adults with serious mental illness.

Official study title

Second generation antipsychotic weight gain and the facilitators and barriers to physical activity for adults with serious mental illness: a qualitative study.

Location not clearly listed
SchizophreniaObservational studyAges 18+
Countries
Sponsor
Julie Ayliffe
Behavioral study icon
RecruitingACTRN12619000838112

The Actionable Intime Insights (AI2) Study: Implementing a digital model for timely and needs-based interventions in mental health services by applying algorithms to health care data

Official study title

Employing a just-in-time adaptive care early intervention approach for a transformational change in the way mental illness is observed, managed and followed-up: The Actionable Intime Insights (AI2) Study

In Australia
Schizophrenia, BipolarityInterventional studyAges 18+
Countries
Australia
Sponsor
Flinders University
Behavioral study icon
Not Yet RecruitingACTRN12624001098527

'Hearing Voices that are Distressing' (HVD) simulation workshop for regional (and rural) health and mental health workers practising in the health sector using a study (CT) leveraging from the regional Teletrial cluster model (National Australian Teletrial Program -ATP-SA) to build a higher level of evidence for lived experience (LE) added-value in simulation methods used for education and training for workers (and students).

Official study title

Hearing Distressing Voices Simulation Workshop for regional (and rural) health and mental health workers: a feasibility Clinical Trial/Teletrial

This study isn't recruiting yet.

In Australia
Schizophrenia, BipolarityInterventional studyAges 18+
Countries
Australia
Sponsor
The University of South Australia Department of Rural Health

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.